Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
NeoGenomics Inc (NEO)  
$13.01 0.12 (0.91%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 127,470,000
Market Cap: 1.66(B)
Last Volume: 878,666 Avg Vol: 1,074,261
52 Week Range: $11.665 - $20.73
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,049 9,748 12,417 12,417
Total Sell Value $16,511 $152,803 $201,886 $201,886
Total People Sold 1 2 2 2
Total Sell Transactions 1 3 4 4
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 544
  Page 12 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Shovlin Robert J. President, Clinical Services   •       –      –    2019-03-01 4 A $0.00 $0 D/D 10,944 148,321     -
   Virag Sharon Chief Financial Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 10,944 10,944     -
   Van Oort Douglas M Chairman and CEO   •       •      –    2019-03-01 4 A $0.00 $0 D/D 37,883 2,092,435     -
   Balliet Jennifer VP and Chief Culture Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 2,862 22,862     -
   Balliet Jennifer VP and Chief Culture Officer   •       –      –    2019-02-28 4 S $19.57 $587,100 D/D (30,000) 20,000     -
   Balliet Jennifer VP and Chief Culture Officer   •       –      –    2019-02-28 4 OE $7.52 $230,700 D/D 30,000 50,000     -
   Shovlin Robert J. President, Clinical Services   •       –      –    2019-02-28 4 OE $7.15 $100,000 D/D 13,986 137,377     -
   Shovlin Robert J. President, Clinical Services   •       –      –    2019-02-27 4 S $19.23 $848,716 D/D (44,135) 123,391     -
   Jones Steven C Executive Vice President   •       •      –    2019-02-27 4 S $18.78 $5,387,378 I/I (285,252) 150,000     -
   Cardoza George President, Pharma Services   •       –      –    2019-02-27 4 OE $3.45 $103,500 D/D 30,000 244,089     -
   Shovlin Robert J. President, Clinical Services   •       –      –    2019-02-26 4 S $18.88 $2,678,676 D/D (141,879) 167,526     -
   Shovlin Robert J. President, Clinical Services   •       –      –    2019-02-26 4 OE $7.15 $1,354,667 D/D 186,014 309,405     -
   Jones Steven C Executive Vice President   •       •      –    2019-02-26 4 S $19.24 $281,365 I/I (14,621) 47,657     -
   Hipp Raymond R Director   –       •      –    2019-02-26 4 S $18.90 $357,002 D/D (18,889) 287,580     -
   Hipp Raymond R Director   –       •      –    2019-02-26 4 OE $4.78 $122,646 D/D 18,889 306,469     -
   Bonello William Chief Strategy Officer   •       –      –    2019-02-26 4 S $18.90 $1,137,837 D/D (60,203) 0     -
   Bonello William Chief Strategy Officer   •       –      –    2019-02-26 4 OE $7.52 $473,211 D/D 60,203 60,203     -
   Johnson Kevin C Director   –       •      –    2018-12-21 4 B $11.60 $301,600 D/D 26,000 103,866 2.39     -
   Ge Medical Systems Information Technologies, Inc. Former 10% Owner   –       –      –    2018-12-14 4 S $12.00 $130,021,740 I/I (10,835,145) 0     -
   Tetrault Lynn A. Director   –       •      –    2018-11-19 4 S $15.97 $207,940 D/D (13,000) 38,234     -
   Tetrault Lynn A. Director   –       •      –    2018-11-15 4 OE $6.66 $141,437 D/D 18,888 56,234     -
   Tetrault Lynn A. Director   –       •      –    2018-11-14 4 S $16.16 $80,800 D/D (5,000) 51,234     -
   Jones Steven C Executive Vice President   •       •      –    2018-11-14 4 S $16.50 $91,625 I/I (5,553) 184,271     -
   Jones Steven C Executive Vice President   •       •      –    2018-11-13 4 S $16.66 $593,610 I/I (35,574) 186,000     -
   Balliet Jennifer VP and Chief Culture Officer   •       –      –    2018-11-13 4/A A $0.00 $0 D/D 6,678 20,000     -
  544 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 12 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us